SEC filing record
Primary Source · SEC.gov

Ares Specialty Healthcare Fund (L), L.P.

Fund Vehicle2024 vintageRule 506(b), Section 3(c), Section 3(c)(7)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalFirst saleForm D/A · 2025-11-075 events: 1 first sale, 1 sold increased, 1 investors increasedLast filing 2025-11-07

Raised

$1.0B

Investors

39

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Ares Specialty Healthcare Fund (L), L.P. is a Delaware limited partnership that first filed a Form D on June 27, 2024 and most recently amended it on November 7, 2025, describing itself as a other investment fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(7) and covers pooled investment fund interests. Ares Specialty Healthcare Fund (L), L.P. reported $1,016,690,000 sold from 39 investors in an offering of indefinite size as of the Form D filed November 7, 2025. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names DBS Bank Ltd, associated with None; Ares Management Capital Markets LLC (CRD 166219), associated with None as recipients of sales compensation. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is C/O Ares Management LLC, 245 Park Avenue, 44th Floor, New York, NY 10167.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001947135
Entity NameAres Specialty Healthcare Fund (L), L.P.
ExemptionRule 506(b), Section 3(c), Section 3(c)(7)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(7) of the Investment Company Act: the fund is excluded from investment-company registration because every investor is a qualified purchaser, generally an individual with at least $5 million in investments or an institution with at least $25 million.
Entity TypeLimited Partnership
Jurisdiction of OrganizationDelaware
Issuer AddressC/O Ares Management LLC, 245 Park Avenue, 44th Floor, New York, NY 10167
Phone(212) 750-7300
Industry / Fund TypePooled Investment Fund · Other Investment Fund
Investment Company ActExcluded under Section 3(c)(7) (qualified purchasers only)
Securities TypePooled investment fund interests
First Sale DateJune 28, 2024
Filing DateNovember 7, 2025
Accession Number0001012975-25-000707
Total Offering AmountIndefinite
Total Amount Sold$1,016,690,000
Amount Sold NoteCombined figure across related vehicles: Total Amount Sold is aggregated to include all Issuers, including certain amounts attributable to Ares and its affiliates.
Total Investors39
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Sales Commissions$0 (to DBS Bank Ltd and 1 other)
Finders' Fees$0
Net Asset Value RangeNot Applicable
State (Issuer Address)CA
Amendment Count2 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

5

latest Nov 7, 2025

Critical / warning

1 / 0

2 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event First sale · Nov 7, 2025

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 5 filing events with values and deltas, latest 2025-11-07, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Adviser of Record (Form ADV)

Ares Capital Management LLC

CRD 131619 · SEC-registered adviser · lists this fund on Schedule D 7.B.(1) as a hedge fund

Auditor named on Form ADV: Ernst & Young LLP · PCAOB-registered per the adviser

From the adviser's Form ADV as loaded from the SEC bulk data, joined on this issuer's Form D file number. Fund-level figures and the adviser's full fund roster are in the terminal.

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Ares SH Management, L.P.

Director · Los Angeles, CA

General partner of the Issuers.

Ares SH Management GP, LLC

Director · Los Angeles, CA

General partner of the general partner.

Matthew Jill

Executive Officer · New York, NY

Mitchell Goldstein

Executive Officer · New York, NY

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

DBS Bank Ltd

Associated broker-dealer: None · Singapore, U0 and outside the United States

Ares Management Capital Markets LLCCRD 166219 on BrokerCheck

Associated broker-dealer: None · Los Angeles, CA · Soliciting in all states

Questions About Ares Specialty Healthcare Fund (L), L.P.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Ares Specialty Healthcare Fund (L), L.P.?

Ares Specialty Healthcare Fund (L), L.P. is a Delaware limited partnership that filed a Form D with the SEC on November 7, 2025 as a other investment fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(7) for an offering of pooled investment fund interests.

Is Ares Specialty Healthcare Fund (L), L.P. legit?

AltStreet does not rate legitimacy; it reports the public record. Ares Specialty Healthcare Fund (L), L.P. filed a Form D with the SEC on November 7, 2025 claiming Rule 506(b), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $1,016,690,000 sold to 39 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Ares Specialty Healthcare Fund (L), L.P. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Ares Specialty Healthcare Fund (L), L.P. claimed Rule 506(b), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Ares Specialty Healthcare Fund (L), L.P. raised?

Ares Specialty Healthcare Fund (L), L.P. reported $1,016,690,000 sold from 39 investors in an offering of indefinite size as of the Form D filed November 7, 2025. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone.

Who can invest in Ares Specialty Healthcare Fund (L), L.P.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in Ares Specialty Healthcare Fund (L), L.P.?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling Ares Specialty Healthcare Fund (L), L.P. and how are they paid?

The Form D names DBS Bank Ltd, associated with None; Ares Management Capital Markets LLC (CRD 166219), associated with None as recipients of sales compensation. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Ares Specialty Healthcare Fund (L), L.P.?

The Form D lists 4 related persons: Ares SH Management, L.P., director (General partner of the Issuers); Ares SH Management GP, LLC, director (General partner of the general partner); Matthew Jill, executive officer; Mitchell Goldstein, executive officer. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Ares Specialty Healthcare Fund (L), L.P. located?

The issuer's address on its SEC filings is C/O Ares Management LLC, 245 Park Avenue, 44th Floor, New York, NY 10167. Its phone number of record is 212-750-7300. It is organized under the laws of Delaware.

How long is the Ares Specialty Healthcare Fund (L), L.P. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.

How large is Ares Specialty Healthcare Fund (L), L.P.?

The Form D reports an aggregate net asset value range of Not Applicable.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.